Clinical trial
Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS
NCT00232193 · Providence Multiple Sclerosis Center, Other · Completed
Key facts
| NCT number | NCT00232193 |
|---|---|
| Title | Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS |
| Official title | Steroid Adjunctive Treatment at Initiation of Avonex Therapy for Patients With Mono-Symptomatic or Relapsing-Remitting Multiple Sclerosis |
| Lead sponsor | Providence Multiple Sclerosis Center, Other |
| Collaborators | Biogen Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Relapsing-remitting Multiple Sclerosis, Clinically Isolated Syndrome |
| Enrollment | 40 |
| Start date | Dec 1, 2003 |
| Primary completion | Dec 1, 2008 |
| Completion | Aug 1, 2010 |
| First posted | Oct 4, 2005 |
| Last update posted | Jul 22, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: